BEMFOLA

Subcutaneous biosimilar medications for patient self-administration

COMMERCIAL BRAND
BEMFOLA

ACTIVE PRINCIPLE
FOLLITROPIN ALFA

TYPE OF DEVICE
PRE-FILLED SYRINGE

LATEX
DO NOT

TEMPERING TIME
5 to 10 min

START OF INJECTION
Inserting the needle into the skin

CLICK TO THE START (IN PEN)
DO NOT

CLICK AT THE END (IN PEN)
DO NOT